These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2690426)

  • 1. Cytochrome P-450 catalysis: radical intermediates and dehydrogenation reactions.
    Ortiz de Montellano PR
    Trends Pharmacol Sci; 1989 Sep; 10(9):354-9. PubMed ID: 2690426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
    de Visser SP; Shaik S
    J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical intermediates in the catalytic cycles of cytochrome P-450.
    Vaz AD; Roberts ES; Coon MJ
    Basic Life Sci; 1988; 49():501-7. PubMed ID: 2854994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monooxygenase, peroxidase and peroxygenase properties and reaction mechanisms of cytochrome P450 enzymes.
    Hrycay EG; Bandiera SM
    Adv Exp Med Biol; 2015; 851():1-61. PubMed ID: 26002730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical intermediates in the catalytic oxidation of hydrocarbons by bacterial and human cytochrome P450 enzymes.
    Jiang Y; He X; Ortiz de Montellano PR
    Biochemistry; 2006 Jan; 45(2):533-42. PubMed ID: 16401082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P-450-catalyzed dehydrogenation of 1,4-dihydropyridines.
    Guengerich FP; Böcker RH
    J Biol Chem; 1988 Jun; 263(17):8168-75. PubMed ID: 3372517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of activation of phenacetin to reactive metabolites by cytochrome P-450: a theoretical study involving radical intermediates.
    Koymans L; Van Lenthe JH; Donné-op Den Kelder GM; Vermeulen NP
    Mol Pharmacol; 1990 Mar; 37(3):452-60. PubMed ID: 2314392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-catalysed dehydrogenation or lactonization of C(sp
    Zhou S; Zhang ZJ; Yu JQ
    Nature; 2024 May; 629(8011):363-369. PubMed ID: 38547926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized cytochrome P450-mediated oxidation and oxygenation reactions in aromatic substrates with activated N-H, O-H, C-H, or S-H substituents.
    Koymans L; Donné-Op den Kelder GM; te Koppele JM; Vermeulen NP
    Xenobiotica; 1993 Jun; 23(6):633-48. PubMed ID: 8212737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oxidative inactivation of cytochrome P450 in monooxygenase reactions.
    Karuzina II; Archakov AI
    Free Radic Biol Med; 1994 Jan; 16(1):73-97. PubMed ID: 8299999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of the 2,2,6,6-tetramethylpiperidine moiety to a 2,2-dimethylpyrrolidine by cytochrome P450: evidence for a mechanism involving nitroxide radicals and heme iron.
    Yin W; Mitra K; Stearns RA; Baillie TA; Kumar S
    Biochemistry; 2004 May; 43(18):5455-66. PubMed ID: 15122911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1).
    Albano E; Comoglio A; Clot P; Iannone A; Tomasi A; Ingelman-Sundberg M
    Biochim Biophys Acta; 1995 Apr; 1243(3):414-20. PubMed ID: 7727516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
    Bachur NR; Gordon SL; Gee MV; Kon H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):954-7. PubMed ID: 34156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical cation intermediates in N-dealkylation reactions.
    Guengerich FP; Okazaki O; Seto Y; Macdonald TL
    Xenobiotica; 1995 Jul; 25(7):689-709. PubMed ID: 7483667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Free oxygen radiacals and kidney diseases--part I].
    Sakac V; Sakac M
    Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for the second oxidant in the catalytic cycle of cytochrome P450: a theoretical investigation of the iron(III)-hydroperoxo species and its epoxidation pathways.
    Ogliaro F; de Visser SP; Cohen S; Sharma PK; Shaik S
    J Am Chem Soc; 2002 Mar; 124(11):2806-17. PubMed ID: 11890833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting heme mechanisms. A perspective on the mechanisms of nitric oxide synthase (NOS), Heme oxygenase (HO), and cytochrome P450s (CYP450s).
    Zhu Y; Silverman RB
    Biochemistry; 2008 Feb; 47(8):2231-43. PubMed ID: 18237198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
    Ebner T; Meese CO; Eichelbaum M
    Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of porphyrin ligands on the regioselective dehydrogenation versus epoxidation of olefins by oxoiron(IV) mimics of cytochrome P450.
    Kumar D; Tahsini L; de Visser SP; Kang HY; Kim SJ; Nam W
    J Phys Chem A; 2009 Oct; 113(43):11713-22. PubMed ID: 19658379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidizing intermediates in cytochrome P450 model reactions.
    Nam W; Ryu YO; Song WJ
    J Biol Inorg Chem; 2004 Sep; 9(6):654-60. PubMed ID: 15365902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.